A joint venture between KAIVA Tech and DRT Strategies has secured a $100 million contract from the Food and Drug Administration for professional, administrative and consulting services.
DRT said Tuesday KAIVA Strategies will provide the FDA with subject matter expertise and consulting in IT, science and medicine, finance, and communications over a five-year period.
PACS contract work is aimed at assisting the agency in achieving its mission.
“DRT has served across the FDA enterprise for nearly 15 years and now we, as a partner in KAIVA Strategies, look forward to continuing to play an important role in collaborating with FDA customers to achieve their goals,” commented Kathy Taylor, senior vice president of growth and alliances at DRT Strategies.
On the other hand, Steven Covey, chief strategy officer at KAIVA Tech and managing partner at KAIVA Strategies, welcomed the opportunity to deliver Health and Scientific Professional Consulting services to the FDA.
About KAIVA Strategies
KAIVA Strategies is a certified Small Business Administration 8(a) approved Mentor Protege JV that has a combined three decades of expertise and capability in providing technology-forward services to address public health, safety and security requirements.
Register now to learn more about the transformative trends and innovations shaping the future of the healthcare sector at the Potomac Officers Club’s 2024 Healthcare Summit.
